Presentation title : Subretinal gene therapy laru-zova for X-linked retinitis pigmentosa (XLRP): Phase 2 DAWN trial, preliminary month 9+ results Date : Thursday, September 4, 2025 Presenter : Rajiv ...

WILMINGTON, DE, UNITED STATES, August 21, 2025 /EINPresswire.com/ -- The global pigments market is witnessing significant ...

With this milestone, VG801 now holds RMAT, Rare Pediatric Disease, and Orphan Drug designations. VeonGen has also been selected to collaborate with the FDA under the Rare Disease Endpoint Advancement ...

Many Indians neglect annual eye exams, risking undetected health issues. Subtle signs like blurry vision, frequent headaches, or eye pain often go ignored. These symptoms can indicate serious ...

The Driving and Vehicle Licensing Agency (DVLA) could slap drivers with a £1,000 fine if they fail to report certain health conditions to the motoring authority.